Evelo Biosciences Inc (EVLO) Annual Balance Sheets

Annual · GAAP · USD millions
Access EVLO quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Evelo Biosciences Inc manages assets, liabilities, and equity through different cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent47.94
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments47.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.63
Total Current Assets51.57
Equipment/Property/Plant Net4.84
Other Assets, Noncurrent3.00
Operating Lease Right Of Use Asset6.87
Total Assets64.44
Liabilities
Accounts Payable, Current AC1.76
Accrued Liabilities, Current AC7.95
Other Liabilities, Current0.43
Total Current Liabilities12.40
Long-term debt43.61
Total Long-term Debt43.61
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent13.42
Operating Lease Liability Current2.26
Operating Lease Liability Noncurrent5.27
Total Liabilities69.43
Stockholders' Equity
Common Stock Value0.11
Additional Paid In Capital Common Stock524.12
Retained Earnings / Accumulated Deficit-529.22
Other Equity0.00
Common Stockholder's Equity-4.99
Total Stockholder's Equity-4.99
Liabilities & Stockholder's Equity64.44
4 historic quarters locked

Sign in to unlock the full Evelo Biosciences Inc balance sheet history.

About Evelo Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001694665-23-000182

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.